The Direct IGF-1 RIA (200 Tubes) is for the quantitative determination of IGF-I in human serum and plasma. Research Use Only. Not for Use in Diagnostic Procedures.
In order to dissociate IGF-I from the IGFBPs, the samples must be diluted in an acidic buffer. The diluted samples are then pipetted into the assay tubes. The IGF-I antiserum containing an excess of IGF-II is dissolved in a buffer, which is able to neutralize the acidic samples. After the IGF-I antibody solution has neutralized the samples, the excess IGF-II occupies the IGF-binding sites of the binding proteins, thus allowing the measurement of free IGF-I. With this method, the IGFBPs are not removed, but their function and therefore their interference in the assay is neutralized. Due to the extremely low cross-reactivity of th eIGF-I antibody with IGF-II, excess IGF-II does not disturb the interaction of the first antibody with IGFI or IGF-I tracer. The assay is then continued like conventional RIA using a second antibody for the separation of bound and free tracer. The color of the solutions makes possible for every tube a control of the respective performance step. This enables you to check your pipette plan, if necessary. Dilution and acidification buffer (including the reconstituted standards and diluted samples) are colored in green through addition of a pH indicator dye. After addition of the uncolored IGF-I antibody solution, the now neutralized solutions turn blue. Finally, addition of the red-colored tracer solution turns the entire incubation color violet.
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.
Complement System Solutions for Drug Development and Clinical Research Datasheet
The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.
Melatonin Products for Sleep Disorder-Related Research Datasheet
The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.